Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by wildbird1on Jun 05, 2022 10:32am
581 Views
Post# 34732429

RE:Difficult-to-value$-TLT...

RE:Difficult-to-value$-TLT...A little complementary note about Chemotherapy.

As claimed in this article healthline.com/health/chemotherapy#procedure

Under Long-term effects...
Chemotherapy long-term effects could include...damage to the
-Heart
-Kidneys
-Lungs
-Nerves
-Reproductive organ
-There is also a chance of developing a second cancer as a results of the chemotherapy treatment itself.

Those are all frightening Long-term effects.
Chemotherapy did save many lives, but today cancer patients need to have access to cancer treatments with almost no side effects.


wildbird1 wrote: In a March 12,2022 interview DrMcFarland said " TLT patients have already failed other forms(with an s) of cancer therapy and their only option at this time is to have their bladder removed ".

For TLT cancer patients.
-Surgery doesn't work...
-BCG doesn't work...
-Chemotherapy & Radiotherapy doesn't work...
-Nothing works.

If TLT does negotiate a JV or a buyout deal with a Big Pharma, the selling points for TLT will be many.
1)TLT cancer treatment has a very high CR% (optimized patients).
2)TLT cancer treatment has almost no side effects.
3)TLT cancer treatment can cure patients that surgery couldn't cure.
4)TLT cancer treatment can cure patients that BCG couldn't cure.
5)TLT cancer treatment can cure patients that Chemotherapy & Radiotherapy couldn't cure.
6) TLT cancer treatment will be adapted to cure other cancers, GBM (Glio blastoma multiforme), NSCLC (Non-Small Cell Lung Cancer).
7)Cocid-19 Vaccine.

Because of all the above it is almost impossible to place a $ value on a Big Pharma JV or a Buyout deal.
But we can certainly say that it does augur very well in favor of TLT.

For now let the manipulation play the SP, just sit tight and wait for the next CR% report that will continue to be better and better, and will add more value$ to TLT.





<< Previous
Bullboard Posts
Next >>